Regulation of endogenous tissue-type plasminogen activator expression is modulated by the -7351C>T enhancer polymorphism.
Tjärnlund-Wolf
A
A
Olsson
L
L
Medcalf
R L
RL
Jern
C
C
D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000187:drug effects / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000235:genetics*; D005838:Genotype; D006801:Humans; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic / Q000187:drug effects; D012333:RNA, Messenger / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000819:agonists; D010959:Tissue Plasminogen Activator / Q000235:genetics* / Q000378:metabolism; D014212:Tretinoin / Q000819:agonists; D042461:Vascular Endothelial Growth Factor A / Q000494:pharmacology
D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; D014212:Tretinoin; D010959:Tissue Plasminogen Activator; D013755:Tetradecanoylphorbol Acetate